Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Availability and Affordability of Selected Medicines in the Islamic Republic of Iran; [Disponibilite Et Accessibilite Economique De Certains Medicaments En Republique Islamique D’Iran] Publisher Pubmed



Ghanbari AR1 ; Moazen M1 ; Azizi A2, 3 ; Abdollahiasll A4 ; Soleymani F1, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pharmacoeconomics and Pharmaceutical Management, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran
  3. 3. Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran
  4. 4. Pharmaceutical Management and Economic Research Center, The Institute of Pharmaceutical Sciences, Tehran University of Medical sciences, Tehran, Iran

Source: Eastern Mediterranean Health Journal Published:2024


Abstract

Background: There is a standard methodology for measuring and evaluating the availability and affordability of selected medicines in the healthcare system, especially in low-and middle-income countries. Aim: To investigate availability, affordability and accessibility of medicines in the Islamic Republic of Iran in 2021 and compare the results with those from 2019. Methods: This descriptive cross-sectional study investigated the availability and affordability of 60 selected medicines in Islamic Republic of Iran. Availability and affordability were measured using the WHO/Health Action International methodology. Results: The availability rates for originator brands in the public, private and other sectors were 6.4%, 8.6% and 6.8%, respectively. In contrast, availability rates for lowest-priced and most-sold generics were 44.7% and 63.6% in the public sector, 45.4% and 66.4% in the private sector, and 39.6% and 58.6% in other sectors. Only 20.0% of originator brands in the Islamic Republic of Iran were affordable, while 96.6% of the lowest priced and 95.0% of the most sold generics were affordable. Conclusion: Most medicines in the Islamic Republic of Iran were affordable and the pharmaceutical supply chain was acceptable. © Authors 2024.
Related Docs
1. Availability and Affordability of Cardiovascular Medicines in a Major City of Afghanistan in 2020, DARU# Journal of Pharmaceutical Sciences (2022)
2. Health System to Response to Economic Sanctions: Global Evidence and Lesson Learned From Iran, Globalization and Health (2022)
3. The Human Cost of Economic Sanctions and Strategies for Building Health System Resilience: A Scoping Review of Studies in Iran, International Journal of Health Planning and Management (2023)
4. Transparency in Public Pharmaceutical Sector: The Key Informants’ Perceptions From a Developing Country, BMC Health Services Research (2021)
Experts (# of related papers)
Haniye Sadat Sajadi (2)
Arash Rashidian (1)